The Conduct and Reporting of Child Health Research: An Analysis of Randomized Controlled Trials Published in 2012 and Evaluation of Change over 5 Years

Journal of Pediatrics

Volumn 193, Issue , 2018, Pages 237-244.e37

  Gates, Allison ^a   Hartling, Lisa ^a   Vandermeer, Ben ^a   Caldwell, Patrina ^b   Contopoulos Ioannidis, Despina G ^c   Curtis, Sarah ^d   Fernandes, Ricardo M ^e,f   Klassen, Terry P ^g   Williams, Katrina ^h   Dyson, Michele P ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF SYDNEY   (Australia)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF ALBERTA   (Canada)

^e INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^f HOSPITAL DE SANTA MARIA   (Portugal)

^g UNIVERSITY OF MANITOBA   (Canada)

^h UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

bias; clinical studies; medicine; pediatrics; research design

Indexed keywords

ARTICLE; BIBLIOGRAPHIC DATABASE; CHILD; CHILD HEALTH; CLINICAL RESEARCH; EFFECT SIZE; EVALUATION STUDY; FISHER EXACT TEST; HUMAN; ICD-10; MEDICAL LITERATURE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK; STUDY DESIGN; METHODOLOGY; PUBLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); STATISTICAL BIAS; STATISTICS AND NUMERICAL DATA;

BIAS; CHILD; CHILD HEALTH; HUMANS; PUBLICATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN;

EID: 85035003153     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2017.09.014     Document Type: Article

References (43)

1. Schulz, K.F., Altman, D.G., Moher, D., CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. Int J Surg 9 (2011), 672–677.
2. Moher, D., Hopewell, S., Schulz, K.F., Montori, V., Gøtzsche, P.C., Devereaux, P.J., et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. Int J Surg 10 (2012), 28–55.
3. Hartling, L., Hamm, M., Klassen, T., Chan, A.W., Meremikwu, M., Moyer, V., et al. Standard 2: containing risk of bias. Pediatrics 129:Suppl 3 (2012), S124–S131.
4. Thomson, D., Hartling, L., Cohen, E., Vandermeer, B., Tjosvold, L., Klassen, T.P., Controlled trials in children: quantity, methodological quality and descriptive characteristics of pediatric controlled trials published 1948-2006. PLoS ONE, 5, 2010, e13106.
5. Hamm, M.P., Hartling, L., Milne, A., Tjosvold, L., Vandermeer, B., Thomson, D., et al. A descriptive analysis of a representative sample of pediatric randomized controlled trials published in 2007. BMC Pediatr, 10, 2010, 96.
6. Higgins, J.P.T., Green, S., (eds.) Cochrane handbook for systematic reviews of interventions, Version 5.1.0, 2011, The Cochrane Collaboration, London, UK.
7. Jadad, A.R., Moore, R.A., Carroll, D., Jenkinson, C., Reynolds, D.J., Gavaghan, D.J., et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 17 (1996), 1–12.
8. The EQUATOR Network [Internet], The EQUATOR Network: what we do and how we are organised. Oxford, UK: The Equator Network http://www.equator-network.org/about-us/equator-network-what-we-do-and-how-we-are-organised/. (Accessed 5 June 2017)
9. Chan, A.W., Tetzlaff, J.M., Gøtzsche, P.C., Altman, D.G., Mann, H., Berlin, J.A., et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ, 346, 2013, e7586.
10. Chan, A.W., Tetzlaff, J.M., Altman, D.G., Laupacis, A., Gøtzsche, P.C., Krleža-Jerić K., et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med 158 (2013), 200–207.
11. Al-Shahi Salman, R., Beller, E., Kagan, J., Hemminki, E., Phillips, R.S., Savulescu, J., et al. Increasing value and reducing waste in biomedical research regulation and management. Lancet 383 (2014), 176–185.
12. Chalmers, I., Bracken, M.B., Djulbegovic, B., Garattini, S., Grant, S., Grant, J., et al. How to increase value and reduce waste when research priorities are set. Lancet 383 (2014), 156–165.
13. Chan, A.W., Song, F., Vickers, A., Jefferson, T., Dickersin, K., Gøtzsche, P.C., et al. Increasing value and reducing waste: addressing inaccessible research. Lancet 383 (2014), 257–266.
14. Glasziou, P., Altman, D.G., Bossuyt, P., Bourton, I., Clarke, M., Julious, S., et al. Reducing waste from incomplete or unusable reports of biomedical research. Lancet 383 (2014), 267–276.
15. Ioannidis, J.P., Greenland, S., Hlatky, M.A., Khoury, M.J., Macleod, M.R., Moher, D., et al. Increasing value and reducing waste in research design, conduct, and analysis. Lancet 383 (2014), 166–175.
16. Turner, L., Shamseer, L., Altman, D.G., Schulz, K.F., Moher, D., Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane review. Syst Rev, 1, 2012, 60.
17. Hartling, L., Wittmeier, K.D., Caldwell, P., van der Lee, H., Klassen, T.P., Craig, J.C., et al. StaR child health: developing evidence-based guidance for the design, conduct, and reporting of pediatric trials. Pediatrics 129:Suppl 3 (2012), S112–S117.
18. Caldwell, P.H., Dans, L., de Vries, M.C., Newman Ba Hons, J., Sammons, H., Spriggs, M., et al. Standard 1: consent and recruitment. Pediatrics 129:Suppl 3 (2012), S118–S123.
19. Ellenberg, S., Fernandes, R.M., Saloojee, H., Bassler, D., Askie, L., Vandermeer, B., et al. Standard 3: data monitoring committees. Pediatrics 129:Suppl 3 (2012), S132–S137.
20. Sinha, I.P., Altman, D.G., Beresford, M.W., Boers, M., Clake, M., Craig, J., et al. Standard 5: selection, measurement, and reporting of outcomes in clinical trials in children. Pediatrics 129:Suppl 3 (2012), S146–S152.
21. van der Tweel, I., Askie, L., Vandermeer, B., Ellenberg, S., Fernandes, R.M., Sallojee, H., et al. Standard 4: determining adequate sample sizes. Pediatrics 129:Suppl 3 (2012), S138–S145.
22. Williams, K., Thomson, D., Seto, I., Contopoulos-Ioannidis, D.G., Ioannidis, J.P., Curtis, S., et al. Standard 6: age groups for pediatric trials. Pediatrics 129:Suppl 3 (2012), S153–S160.
23. Joseph, P.D., Craig, J.C., Caldwell, P.H., Clinical trials in children. Br J Clin Pharmacol 79 (2015), 357–369.
24. Cochrane Library [Internet], Cochrane central register of controlled trials (CENTRAL). Hoboken (NJ): John Wiley and Sons http://www.cochranelibrary.com/about/central-landing-page.html. (Accessed 5 June 2017)
25. Higgins, J.P., Altman, D.G., Gøtzsche, P.C., Jüni, P., Moher, D., Oxman, A.D., et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ, 343, 2011, d5928.
26. Borenstein, M.H.L., Higgins, J.P.T., Rothstein, H.R., Converting among effect sizes. Introduction to Meta-analysis. 2009, John Wiley and Sons, Chichester, UK.
27. World Health Organization [Internet], Classifications. 2016, World Health Organization, Geneva, Switzerland updated November 29 http://www.who.int/classifications/icd/en/. (Accessed 5 June 2017)
28. Crocetti, M.T., Amin, D.D., Scherer, R., Assessment of risk of bias among pediatric randomized controlled trials. Pediatrics 126 (2010), 298–305.
29. Wood, L., Egger, M., Gluud, L.L., Schulz, K.F., Jüni, P., Altman, D.G., et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ 336 (2008), 601–605.
30. DeAngelis, C.D., Drazen, J.M., Frizelle, F.A., Haug, C., Hoey, J., Horton, R., et al. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. JAMA 292 (2004), 1363–1364.
31. Killeen, S., Sourallous, P., Hunter, I.A., Hartley, J.E., Grady, H.L., Registration rates, adequacy of registration, and a comparison of registered and published primary outcomes in randomized controlled trials published in surgery journals. Ann Surg 259 (2014), 193–196.
32. Rosati, P., Porzsolt, F., Ricciotti, G., Testa, G., Inglese, R., Giustini, F., et al. Major discrepancies between what clinical trial registries record and paediatric randomised controlled trials publish. Trials, 17, 2016, 430.
33. Huic, M., Marusic, M., Marusic, A., Completeness and changes in registered data and reporting bias of randomized controlled trials in ICMJE journals after trial registration policy. PLoS ONE, 6, 2011, e25258.
34. Berendt, L., Callreus, T., Petersen, L.G., Bach, K.F., Poulsen, H.E., Dalhoff, K., From protocol to published report: a study of consistency in the reporting of academic drug trials. Trials, 17, 2016, 100.
35. Farquhar, C.M., Showell, M.G., Showell, E.A., Beetham, P., Baak, N., Mourad, S., et al. Clinical trial registration was not an indicator for low risk of bias. J Clin Epidemiol 84 (2017), 47–53.
36. Schulz, K.F., Chalmers, I., Hayes, R.J., Altman, D.G., Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 273 (1995), 408–412.
37. Hempel, S., Suttorp, M.J., Miles, J.N.V., Wang, Z., Maglione, M., Morton, S., et al. Empirical evidence of associations between trial quality and effect size. 2011, Agency for Healthcare Research and Quality, Rockville (MD).
38. Perneger, T.V., Combescure, C., The distribution of p-values in medical research articles suggested selective reporting associated with statistical significance. J Clin Epidemiol 87 (2017), 70–77.
39. Mills, E., Wu, P., Gagnier, J., Heels-Ansdell, D., Montori, V.M., An analysis of general medical and specialist journals that endorse CONSORT found that reporting was not enforced consistently. J Clin Epidemiol 58 (2005), 662–667.
40. Hirst, A., Altman, D.G., Are peer reviewers encouraged to use reporting guidelines? A survey of 116 health research journals. PLoS ONE, 7, 2012, e35621.
41. Harriman, S.L., Patel, J., When are clinical trials registered? An analysis of prospective versus retrospective registration. Trials, 17, 2016, 187.
42. Hartling, L., Hamm, M.P., Milne, A., Vandermeer, B., Santaguida, P.L., Ansari, M., et al. Testing the risk of bias tool showed low reliability between individual reviewers and across consensus assessments of reviewer pairs. J Clin Epidemiol 66 (2013), 973–981.
43. Jordan, V.M., Lensen, S.F., Farquhar, C.M., There were large discrepancies in risk of bias tool judgments when a randomized controlled trial appeared in more than one systematic review. J Clin Epidemiol 81 (2017), 72–76.